This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
Communications Biology Open Access 04 November 2020
-
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
Nature Communications Open Access 04 June 2018
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Apetoh, L. et al. Nat. Med. 13, 1050–1059 (2007).
Obeid, M. et al. Nat. Med. 13, 54–61 (2007).
Ghiringhelli, F. et al. Nat. Med. 15, 1170–1178 (2009).
Schreiber, K., Rowley, D.A., Riethmuller, G. & Schreiber, H. Hematol. Oncol. Clin. North Am. 20, 567–584 (2006).
Mattarollo, S.R. et al. Cancer Res. 71, 4809–4820 (2011).
Olive, K.P. et al. Science 324, 1457–1461 (2009).
Willimsky, G. et al. J. Exp. Med. 205, 1687–1700 (2008).
DeNardo, D.G. et al. Cancer Discov. 1, 54–67 (2011).
Ramakrishnan, R. et al. J. Clin. Invest. 120, 1111–1124 (2010).
Robert, C. et al. N. Engl. J. Med. 364, 2517–2526 (2011).
Acknowledgements
We thank T.N. Schumacher for helpful discussions. We thank the protein facility at the Netherlands Cancer Institute for providing the antibody against CD8. Research described in this Correspondence was supported by grants from the Dutch Cancer Society (KWF grants 2006-3715 and 2011-5004 to K.E.d.V. and J.J.), the Netherlands organization for Scientific Research (NWO grant VIDI 917.96.307 to K.E.d.V.) and the Association for International Cancer Research (AICR grant 11-0677 to K.E.d.V.).
Author information
Authors and Affiliations
Contributions
J.J. and K.E.d.V. designed the study. M.C., C.-S.H. and C.W.D. performed the experiments. K.E.d.V. took the initiative for this Correspondence and wrote the manuscript. All coauthors provided comments that helped shape the final submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–3 and Supplementary Methods (PDF 189 kb)
Rights and permissions
About this article
Cite this article
Ciampricotti, M., Hau, CS., Doornebal, C. et al. Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system. Nat Med 18, 344–346 (2012). https://doi.org/10.1038/nm.2652
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2652
This article is cited by
-
De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors
Communications Biology (2020)
-
The pro-tumorigenic host response to cancer therapies
Nature Reviews Cancer (2019)
-
Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response
Nature Cell Biology (2019)
-
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer
Nature Communications (2018)
-
Mouse models in oncoimmunology
Nature Reviews Cancer (2016)